Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Oncological care organisation during COVID-19 outbreak
Download the file


Download Analytics Citations

Export to: EndNote


This file is in the following collections:

COVID-19 Community

Oncological care organisation during COVID-19 outbreak Open Access (recommended)


Resource type(s)
Journal Article
oncological care
Attribution-NonCommercial 3.0 United States

Onesti, Concetta Elisa
Rugo, Hope S.
Generali, Daniele
Peeters, Marc
Zaman, Khalil
Wildiers, Hans
Harbeck, Nadia
Martin, Miguel
Cristofanilli, Massimo
Cortes, Javier
Tjan-Heijnen, Vivianne
Hurvitz, Sara A.
Berchem, Guy
Tagliamento, Marco
Campone, Mario
Bartsch, Rupert
De Placido, Sabino
Puglisi, Fabio
Rottey, Sylvie
Mueller, Volkmar
Ruhstaller, Thomas
Machiels, Jean-Pascal
Conte, PierFranco
Awada, Ahmad
Jerusalem, Guy
Background COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA. Methods A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit. Results Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres. Conclusion Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies.
Original Bibliographic Citation
Onesti CE, Rugo HS, Generali D, Peeters M, Zaman K, Wildiers H, Harbeck N, Martin M, Cristofanilli M, Cortes J, Tjan-Heijnen V, Hurvitz SA, Berchem G, Tagliamento M, Campone M, Bartsch R, De Placido S, Puglisi F, Rottey S, Muller V, Ruhstaller T, Machiels JP, Conte P, Awada A, Jerusalem G. Oncological care organisation during COVID-19 outbreak. Esmo Open. 2020;5(4):8.
Related URL
Date Created
Original Identifier
(PMID) 32847836
Subject: MESH
Oncology Service, Hospital
Subject: LCSH
Cancer--Patients--Hospital care
COVID-19 Pandemic, 2020---Influence
Grants and funding
Fonds de la Recherche Scientifique
Fonds de la Recherche Scientifique - FNRS
Fondation Leon Fredericq

File Details

File Properties
Mime type: application/pdf
File size: 1111.9 kB